Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 56 of Aptevo Therapeutics Inc.'s SEC filings and found 12 warrant series, 1 ATM program, 3 equity lines, 4 shelf registrations, 8 S-1 registrations and 1 completed offering on file for APVO. The latest dilution event on file is ATM sales on Oct 30, 2026. Analysis updated Nov 2, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
DRMADermata Therapeutics, Inc.
LIMNLiminatus Pharma, Inc. Class A Common Stock
CVKDCadrenal Therapeutics, Inc. Common Stock
PMCBPharmaCyte Biotech, Inc.
ERNAErnexa Therapeutics Inc.
GRIGRI Bio, Inc.
KALAKALA BIO, Inc.
JUNSJupiter Neurosciences, Inc.
CMNDClearmind Medicine Inc.
HLSQTessera Defense and Homeland Security Inc
SXTP60 Degrees Pharmaceuticals, Inc.
APUSApimeds Pharmaceuticals US, Inc
MDCXMedicus Pharma Ltd. Common Stock
AIMDAinos, Inc.
REVBRevelation Biosciences, Inc.